Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21284407rdf:typepubmed:Citationlld:pubmed
pubmed-article:21284407lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:21284407lifeskim:mentionsumls-concept:C0750848lld:lifeskim
pubmed-article:21284407lifeskim:mentionsumls-concept:C0036043lld:lifeskim
pubmed-article:21284407lifeskim:mentionsumls-concept:C0406317lld:lifeskim
pubmed-article:21284407lifeskim:mentionsumls-concept:C0282461lld:lifeskim
pubmed-article:21284407lifeskim:mentionsumls-concept:C0460977lld:lifeskim
pubmed-article:21284407lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:21284407pubmed:issue3lld:pubmed
pubmed-article:21284407pubmed:dateCreated2011-4-7lld:pubmed
pubmed-article:21284407pubmed:abstractTextCorticosteroids are a versatile option for the treatment of mild-to-moderate psoriasis due to their availability in a wide range of potencies and formulations. Occlusion of the corticosteroid is a widely accepted procedure to enhance the penetration of the medication, thereby improving its effectiveness. Betamethasone valerate (BMV) is a moderately potent corticosteroid that is available as a cream, ointment, and lotion. A ready-to-use occlusive dressing, which provides a continuous sustained release of BMV, has been developed for the treatment of psoriasis.lld:pubmed
pubmed-article:21284407pubmed:languageenglld:pubmed
pubmed-article:21284407pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21284407pubmed:citationSubsetIMlld:pubmed
pubmed-article:21284407pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21284407pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21284407pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21284407pubmed:statusMEDLINElld:pubmed
pubmed-article:21284407pubmed:monthJunlld:pubmed
pubmed-article:21284407pubmed:issn1175-0561lld:pubmed
pubmed-article:21284407pubmed:authorpubmed-author:NaldiLuigiLlld:pubmed
pubmed-article:21284407pubmed:authorpubmed-author:OrtonneJean-P...lld:pubmed
pubmed-article:21284407pubmed:authorpubmed-author:YawalkarNikhi...lld:pubmed
pubmed-article:21284407pubmed:authorpubmed-author:KaszubaAndrze...lld:pubmed
pubmed-article:21284407pubmed:authorpubmed-author:MorelliPaoloPlld:pubmed
pubmed-article:21284407pubmed:authorpubmed-author:RovatiStefano...lld:pubmed
pubmed-article:21284407pubmed:authorpubmed-author:MautoneGiusep...lld:pubmed
pubmed-article:21284407pubmed:issnTypePrintlld:pubmed
pubmed-article:21284407pubmed:day1lld:pubmed
pubmed-article:21284407pubmed:volume12lld:pubmed
pubmed-article:21284407pubmed:ownerNLMlld:pubmed
pubmed-article:21284407pubmed:authorsCompleteYlld:pubmed
pubmed-article:21284407pubmed:pagination191-201lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:meshHeadingpubmed-meshheading:21284407...lld:pubmed
pubmed-article:21284407pubmed:year2011lld:pubmed
pubmed-article:21284407pubmed:articleTitleEfficacy and safety of the Betamethasone valerate 0.1% plaster in mild-to-moderate chronic plaque psoriasis: a randomized, parallel-group, active-controlled, phase III study.lld:pubmed
pubmed-article:21284407pubmed:affiliationClinica Dermatologica, Ospedali Riuniti, Centro Studi GISED, Bergamo, Italy.lld:pubmed
pubmed-article:21284407pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21284407pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:21284407pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:21284407pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:21284407pubmed:publicationTypeClinical Trial, Phase IIIlld:pubmed